Ritter Pharma Revenue, Profits - RTTR Quarterly Income Statement

Add to My Stocks
$1.8 $0.06 (3.45%) RTTR stock closing price Sep 20, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Ritter Pharma stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the RTTR stock. The operating expenses as shown in the Ritter Pharma profit and loss statement for 2018 Q2 total to $3.61M. This line item shows that the operating expenses has increased compared with last year. Also check: Ritter Pharma assets and Ritter Pharma free cash flow.

View and download details of revenue and profits for Ritter Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Ritter Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Ritter Pharma Gross Profit
Research & Development Expense1.87M-----6.19M2.34M2.88M1.88M
Selling General & Admin Expense1.74M1.18M1.5M1.09M1.19M1.24M1.43M1.19M1.27M1.26M
Income Before Depreciation Depletion Amortization-3.61M-2.03M-2.25M-2.01M-1.96M-1.68M-7.61M-3.53M-4.15M-3.15M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
Ritter Pharma Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-3.58M-2.01M-5.1M-2.01M-1.96M-1.67M-7.59M-3.53M-4.14M-3.13M
Extraordinary Items & Discontinued Operations----------
Ritter Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS5.07M4.95M4.64M1.48M1.4M1.16M1.02M---
Average Shares used to compute Basic EPS5.07M4.95M4.64M1.48M1.4M1.16M1.02M---
Income Before Nonrecurring Items-3.59M-2.01M-5.1M-2.01M-1.96M-1.67M-7.59M-3.53M-4.14M-3.13M
Income from Nonrecurring Items----------
Ritter Pharma Earnings Per Share Basic Net
Ritter Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.71-0.41-1.10-1.40-1.40-1.40-7.40-4.10-4.80-3.60
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Ritter Pharma stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Ritter Pharma revenue chart, implies that the company is growing. It has not been the case with Ritter Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-3.58M for Ritter Pharma for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The RTTR financials along with Ritter Pharma historical stock prices provide a lot of details about the firm.

Ritter Pharma Income Statement - Key Financial Ratios